STRIATAL GLUTAMATE RECEPTORS DURING DEVELOPMENT

发育过程中的纹状体谷氨酸受体

基本信息

  • 批准号:
    3087106
  • 负责人:
  • 金额:
    $ 6.87万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    1991
  • 资助国家:
    美国
  • 起止时间:
    1991-08-01 至 1994-06-30
  • 项目状态:
    已结题

项目摘要

This application proposes a series of experiments to investigate the development of striatal glutamate receptor subtypes in the rat and cat brain. The striatum is known to participate in the planning and execution of movement, and more recently has been found to play a role in cognition, learning, and behavior. Structurally, the striatum is comprised of at least two compartments, the patches and the matrix, which share afferent and efferent connections. The existence of two parallel but distinct circuits provides a capacity for integration and modulation of information both to and from the striatum. To date, the patch and matrix compartments have been defined primarily by immunohistochemical and autoradiographic techniques. The patches appear in the striatum earlier than the matrix, and they are richer in opiate receptors and dopamine than the surrounding matrix. Acetylcholinesterase (AChE) activity is higher in patches than in matrix in fetal and noenatal rat and cat, only to reverse the pattern during aging. The adult rat and cat exhibit AChE-poor patches and AChE-rich matrix. Glutamate is the neurotransmitter of the cortical projections to the striatum, and there is preliminary evidence using quantitative in vitro autoradiography to suggest a patchy distribution of striatal glutamate receptor binding in neonatal rat, adult cat, and in infant and adult human brain. The subtype of glutamate receptor defined by the binding of the excitatory amino acid (EAA) N-methyl-D-aspartate (NMDA) has been shown to have a trophic effect in cortical neuronal development, but has not been investigated in the striatum. To determine the pattern of development of striatal glutamate receptors, neonatal rat and fetal kitten brain will be utilized. Quantitative in vitro receptor autoradiography will be used to determine the time course of appearance of the patch-matrix mosaic of receptor binding of the glutamate receptor subtypes (NMDA, iontrophic quisqualate, metabotropic quisqualate, and kainate). Adjacent brain sections will beassayed for AChE activity to compare the patch-matrix mosaic defined by EAA autoradiography to the mosaic defined immunohistochemically. Finally, lesioning experiments will be done to determine the effect that cortical and nigral connections have on the development of the patch- matrix mosaic of EAA receptors. Neonatal rats and kittens will undergo decortication, and fetal kittens will undergo chemically induced nigral lesions with 6-hydroxy dopamine, followed by receptor autoradiography. These manipulations will provide information regarding the role that cortical and nigral connections to the striatum play in the development of the patch-matrix mosaic.
本应用程序提出了一系列的实验来研究

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

LEON S DURE其他文献

LEON S DURE的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('LEON S DURE', 18)}}的其他基金

STRIATAL GLUTAMATE RECEPTORS DURING DEVELOPMENT
发育过程中的纹状体谷氨酸受体
  • 批准号:
    2194472
  • 财政年份:
    1991
  • 资助金额:
    $ 6.87万
  • 项目类别:
STRIATAL GLUTAMATE RECEPTORS DURING DEVELOPMENT
发育过程中的纹状体谷氨酸受体
  • 批准号:
    3087107
  • 财政年份:
    1991
  • 资助金额:
    $ 6.87万
  • 项目类别:
STRIATAL GLUTAMATE RECEPTORS DURING DEVELOPMENT
发育过程中的纹状体谷氨酸受体
  • 批准号:
    3087104
  • 财政年份:
    1991
  • 资助金额:
    $ 6.87万
  • 项目类别:
STRIATAL GLUTAMATE RECEPTORS DURING DEVELOPMENT
发育过程中的纹状体谷氨酸受体
  • 批准号:
    2194471
  • 财政年份:
    1991
  • 资助金额:
    $ 6.87万
  • 项目类别:
STRIATAL GLUTAMATE RECEPTORS DURING DEVELOPMENT
发育过程中的纹状体谷氨酸受体
  • 批准号:
    3087105
  • 财政年份:
    1991
  • 资助金额:
    $ 6.87万
  • 项目类别:
SUPPORT FOR INTERN 1 CONGRESS OF PLANT MOLECULAR BIOLOGY
支持实习生 1 植物分子生物学大会
  • 批准号:
    3434916
  • 财政年份:
    1985
  • 资助金额:
    $ 6.87万
  • 项目类别:
RNA METABOLISM IN DEVELOPMENT AND HORMONAL REGULATION
发育和荷尔蒙调节中的 RNA 代谢
  • 批准号:
    3277987
  • 财政年份:
    1981
  • 资助金额:
    $ 6.87万
  • 项目类别:
TRANSCRIPTION AND TRANSLATION IN A DEVELOPMENTAL SYSTEM
发育系统中的转录和翻译
  • 批准号:
    3275632
  • 财政年份:
    1980
  • 资助金额:
    $ 6.87万
  • 项目类别:
TRANSCRIPTION AND TRANSLATION IN A DEVELOPMENTAL SYSTEM
发育系统中的转录和翻译
  • 批准号:
    3275631
  • 财政年份:
    1980
  • 资助金额:
    $ 6.87万
  • 项目类别:

相似海外基金

Effect of Acetylcholinesterase inhibitors on Bone Metabolism and Fracture Risk Factors among older adults with mild to moderate Alzheimer's Disease
乙酰胆碱酯酶抑制剂对患有轻至中度阿尔茨海默病的老年人骨代谢和骨折危险因素的影响
  • 批准号:
    10739853
  • 财政年份:
    2023
  • 资助金额:
    $ 6.87万
  • 项目类别:
Acetylcholinesterase Complex Protein-Protein Interactions as Drug Targets Against Organophosphate-induced Neurotoxicity.
乙酰胆碱酯酶复合物蛋白质-蛋白质相互作用作为抗有机磷诱导的神经毒性的药物靶点。
  • 批准号:
    10772738
  • 财政年份:
    2023
  • 资助金额:
    $ 6.87万
  • 项目类别:
Machine learning approaches to predict Acetylcholinesterase inhibition
预测乙酰胆碱酯酶抑制的机器学习方法
  • 批准号:
    10378934
  • 财政年份:
    2021
  • 资助金额:
    $ 6.87万
  • 项目类别:
Acetylcholinesterase Complex Protein-Protein Interactions as Drug Targets Against Organophosphate-induced Neurotoxicity.
乙酰胆碱酯酶复合物蛋白质-蛋白质相互作用作为抗有机磷诱导的神经毒性的药物靶点。
  • 批准号:
    10303546
  • 财政年份:
    2021
  • 资助金额:
    $ 6.87万
  • 项目类别:
Investigating the in vivo targets and mechanism of action of a toxic acetylcholinesterase-derived peptide upregulated in Alzheimer's disease
研究阿尔茨海默病中上调的有毒乙酰胆碱酯酶衍生肽的体内靶点和作用机制
  • 批准号:
    2480200
  • 财政年份:
    2020
  • 资助金额:
    $ 6.87万
  • 项目类别:
    Studentship
Improved Therapeutics for the Resurrection of the Aged Form of Acetylcholinesterase
老化乙酰胆碱酯酶复活的改进疗法
  • 批准号:
    9977281
  • 财政年份:
    2019
  • 资助金额:
    $ 6.87万
  • 项目类别:
Improved Therapeutics for the Resurrection of the Aged Form of Acetylcholinesterase
老化乙酰胆碱酯酶复活的改进疗法
  • 批准号:
    10238898
  • 财政年份:
    2019
  • 资助金额:
    $ 6.87万
  • 项目类别:
Elucidation of the cell protective mechanism of acetylcholinesterase variants in cardiomyocyte and approach to therapy for myocardial infarction
心肌细胞乙酰胆碱酯酶变异体的细胞保护机制的阐明及心肌梗死的治疗方法
  • 批准号:
    18K15850
  • 财政年份:
    2018
  • 资助金额:
    $ 6.87万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Effects of Alzheimer's disease drugs inhibiting acetylcholinesterase on prion replication.
阿尔茨海默病药物抑制乙酰胆碱酯酶对朊病毒复制的影响。
  • 批准号:
    481759-2015
  • 财政年份:
    2015
  • 资助金额:
    $ 6.87万
  • 项目类别:
    Alexander Graham Bell Canada Graduate Scholarships - Master's
Reactivation of Aged Acetylcholinesterase: Design and Development of Novel Therap
老化乙酰胆碱酯酶的重新激活:新型疗法的设计和开发
  • 批准号:
    8735550
  • 财政年份:
    2014
  • 资助金额:
    $ 6.87万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了